Evidence map›Paper›PMID 35631450›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target

Dahyun Kim, Young-Rok Kim, Hee-Jong Hwang, Marco A Ciufolini, Jusuk Lee, Hakyeong Lee, Shyaka Clovis, Sungji Jung, Sang-Hun Oh, Young-Jin Son and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Therapies from Thiopeptides.Molecules (Basel, Switzerland) · 2023
    Review
  3. Microbiology spectrum · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Dahyun KimA&J Science Co., Ltd., 80 Chumbok Ro, Dong Gu, Daegu 41061, Korea.
Young-Rok KimSchool of Life Science, Handong Global University, 558 Handong Ro, Heunghae-Eup, Buk-Gu, Pohang 37554, Korea.
Hee-Jong HwangA&J Science Co., Ltd., 80 Chumbok Ro, Dong Gu, Daegu 41061, Korea.ORCID 0000-0003-1749-7124
Marco A CiufoliniDepartment of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, BC V6K 1Z1, Canada.
Jusuk LeeA&J Science Co., Ltd., 80 Chumbok Ro, Dong Gu, Daegu 41061, Korea.
Hakyeong LeeA&J Science Co., Ltd., 80 Chumbok Ro, Dong Gu, Daegu 41061, Korea.
Shyaka ClovisA&J Science Co., Ltd., 80 Chumbok Ro, Dong Gu, Daegu 41061, Korea.
Sungji JungSchool of Life Science, Handong Global University, 558 Handong Ro, Heunghae-Eup, Buk-Gu, Pohang 37554, Korea.
Sang-Hun OhSchool of Life Science, Handong Global University, 558 Handong Ro, Heunghae-Eup, Buk-Gu, Pohang 37554, Korea.
Young-Jin SonA&J Science Co., Ltd., 80 Chumbok Ro, Dong Gu, Daegu 41061, Korea.
Jin-Hwan KwakSchool of Life Science, Handong Global University, 558 Handong Ro, Heunghae-Eup, Buk-Gu, Pohang 37554, Korea.ORCID 0000-0003-3613-5380
Handong Global University · KRUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The US Centers for Disease Control and Prevention (CDC) lists

Indexed as

Clostridioides difficilenitro-group-containing antibioticsthiopeptide antibiotics

Identifiers

PMID35631450
PMCPMC9142968
OpenAlexW4280584771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.